Risk & Volatility
iCoreConnect has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, iCoreConnect’s rivals have a beta of 0.44, suggesting that their average stock price is 56% less volatile than the S&P 500.
Valuation & Earnings
This table compares iCoreConnect and its rivals revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
iCoreConnect | $8.15 million | -$15.55 million | -0.05 |
iCoreConnect Competitors | $2.43 billion | $336.94 million | 5.95 |
iCoreConnect’s rivals have higher revenue and earnings than iCoreConnect. iCoreConnect is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
Net Margins | Return on Equity | Return on Assets | |
iCoreConnect | -260.79% | -614.22% | -152.86% |
iCoreConnect Competitors | -57.22% | -28.65% | -7.66% |
Insider & Institutional Ownership
13.4% of iCoreConnect shares are owned by institutional investors. Comparatively, 56.9% of shares of all “Prepackaged software” companies are owned by institutional investors. 59.4% of iCoreConnect shares are owned by insiders. Comparatively, 18.9% of shares of all “Prepackaged software” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
iCoreConnect rivals beat iCoreConnect on 7 of the 9 factors compared.
iCoreConnect Company Profile
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.
Receive News & Ratings for iCoreConnect Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCoreConnect and related companies with MarketBeat.com's FREE daily email newsletter.